<DOC>
	<DOCNO>NCT02841605</DOCNO>
	<brief_summary>The close homology central enteric nervous system suggest disease process affect central nervous system could also involve enteric counterpart . The investigator recently show enteric neuron readily analyze use routine colonic biopsy . This lead u propose enteric nervous system could represent unique window ass neuropathology live patient neurodegenerative disorder . The investigator already use approach show Parkinson 's disease pathology recapitulate single colonic biopsy . By contrast Parkinson 's disease , detection Alzheimer 's disease ( AD ) pathology enteric neuron far fail . This may due low number human tissue sample addition low sensitivity immunohistochemical method use . The aim current research project therefore reevaluate AD pathology large number human colonic sample use morphological biochemical approach . The enteric nervous system could represent unique window ass neuropathology live patient AD . This might open way development novel AD biomarkers directly assess neuropathological process . Main Aim : To Analyze presence beta-amyloid pathology enteric nervous system ( ENS ) AD patient Secondary Aim ( ) : 1 . To analyze describe presence tau enteric nervous system ( ENS ) AD patient 2 . To assess neuronal loss submucosal tissue AD patient . 3 . To examine Glia cell enteric nervous system AD patients..</brief_summary>
	<brief_title>Enteric Nervous System Alzheimer Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>AD group : Patient early moderate Alzheimer disease ( continuum patient MCI due AD patient diagnose probable AD ) accord NIA NAA criterion MMSE score ≥18 ; Has one informant care partner ; No parkinsonian syndrome No sign lewy Body dementia PD group ( control group 1 ) : Patients Parkinson Disease accord UKPDSBB criterion , No dementia sign cognitive deficit associate AD PSP group ( control group 2 ) : Patients possible probable Progressive supranuclear palsy group PSP accord NINDS criterion Has one informant care partner ; Patient eligible colorectal cancer screening ( control group 3 ) : No history current neurological/degenerative condition ( e.g , lewy body dementia , PD , Parkinsonian syndrome , AD… ) No memory complaint Mac Nair score ≤15 MMSE score ≥28 ; Patient risk colic cancer colonoscopy schedule For group : History colonic disorder ( e.g inflammatory condition , adenocarcinoma ) History bleed disorder Traitement anticoagulant ou antiagrégant en cours Treatment anticoagulant Platelet aggregation inhibit drug Patient AD , PSP , PD : Any neurological/neurodegenerative condition different group belongs ( e.g AD AD group PD PD group… . ) Patient eligible colorectal cancer screen Any neurological/neurodegenerative condition ( e.g lewy body dementia , Parkinsonian syndrome , PD , AD.. ) .. Functional colopathy Irritable Bowel Syndrome</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>